Outcomes of endovascular abdominal aortic aneurysm repair conversion in octogenarians treated at a high-volume aorta center.

Abstract

Endovascular abdominal aortic aneurysm repair (EVAR) has become the dominant treatment strategy for infrarenal abdominal aortic aneurysms but has been especially preferred for octogenarian (age ≥80years) patients because of concerns surrounding comorbidity severity and physiologic frailty. However, EVAR failure resulting in subsequent open conversion (EVAR-c) has been increasingly reported in older patients, although a paucity of literature focusing on the outcomes in this subgroup is available. The purpose of the present analysis was to evaluate our experience with EVAR-c for octogenarians (age ≥80years) compared with that for younger patients (age<80years). A retrospective review of all nonmycotic EVAR-c procedures (2002-2020) at a single high-volume academic hospital with a dedicated aorta center (available at: https://www.uf-health-aortic-disease-center) was performed. A total of 162 patients were categorized into octogenarian (age ≥80years; n= 43) and nonoctogenarian (age<80years; n= 119) cohorts and compared. The primary end point was 30-day mortality. The secondary end points included complications, 90-day mortality, and overall survival. Cox regression was used to determine the effects of selected covariates on mortality risk. The Kaplan-Meier method was used to estimate survival. No differences in the preadmission EVAR reintervention rates were present (octogenarians, 42%; nonoctogenarians, 43%; P= 1.00) although the interval to the first reintervention was longer for the octogenarians (41months) than for the nonoctogenarians (15months; P= .01). In addition, the time to EVAR-c was significantly longer for the octogenarian patients (61months) than for the nonoctogenarian patients (39months; P< .01). No difference in rupture presentation was evident (14% vs 10%; P= .6). However, elective EVAR-c occurred less frequently for octogenarians (42%) than for nonoctogenarians (59%; P= .07). The abdominal aortic aneurysm diameter was significantly larger for elective octogenarian EVAR-c (7.8± 1.9cm) than for nonoctogenarian EVAR-c (7.0± 1.5cm; P= .02), and the presence of a type Ia endoleak was the most common indication overall (58%; n= 91). A trend toward greater 30-day mortality was evident for octogenarian patients (16%) compared with nonoctogenarian patients (7%; P= .06). Similarly, the 90-day mortality was greater for the octogenarian patients (26%) than for the nonoctogenarian patients (10%; P= .02). However, the incidence of any complication (56% vs 49%; P= .5), readmission rate (12% vs 6%; P= .3), unplanned reoperation rate (10% vs 5%; P= .5), and length of stay (11days vs 9days; P= .3) were not significantly different between the two groups. Age ≥80years was predictive of short-term mortality after nonelective but not after elective surgery. However, increasing comorbidities, nonelective admission, and renal or mesenteric revascularization showed the strongest association with mortality risk. Survival at 1 and 3years was not different between the two groups when comparing all patients after the first 90days postoperatively. Although the unadjusted perioperative mortality was greater for octogenarian patients, the risk-adjusted elective outcomes were comparable to those for younger EVAR-c patients when treated at a high-volume aortic surgery center. This finding underscores the importance of appropriate patient selection and modulation of operative complexity when feasible to achieve optimal results. Providers caring for octogenarian patients with EVAR failure should consider timely elective referral to high-volume aorta centers to reduce resource usage and the frequency of nonelective presentations.